IMMUNO-COV™ – The Test for Antibodies that Block SARS-CoV-2 Infection Read More

September 9-10, 2021

The 27th Annual Meeting of the Japan Society of Gene and Cell Therapy (JSGCT)

Stephen J. Russell, M.D., Ph.D., Vyriad President and Chief Executive Officer. Presentation: “Intravenous Oncolytic Virotherapy Using Voyager-V1 (VSV-IFNb-NIS).”

Visit event site

Media Inquiries

For inquiries, please contact mediarelations@vyriad.com